Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: ⢠Support Holding ⢠Momentum Weakening ⢠Resistance Overhead Support Level: $9.25-$9.35 Resistance Level: $10.00-$10.33 Over the last month, NEOG reversed from a $10.33 peak into a lower-high/lower-low pattern, with $9.25-$9.35 acting as support and $10.00-$10.33 as resistance, so a break below support could retest $8.99.
Sentiment & News
Key News Insights: ⢠Revenue Growth ⢠3M Integration ⢠Margin Pressure Neogen's stock has rerated sharply on strong Food Safety growth, new product launches, and 3M integration progress, though margin and cost pressures still need watching ahead of Q4 results.
AI Summary
NEOG has moved from a speculative turnaround to a proof-of-durability story: Food Safety growth, positive free cash flow, and debt reduction support the case, but persistent supplier disruptions in Animal Safety and rising costs mean the stock likely needs a clean July 30 update showing broad operational normalization before further upside is justified.
Description
Neogen Corporation develops, manufactures and sells products used to detect, mitigate and monitor biological, chemical and sanitary hazards across the food and animal sectors. Its Food Safety business supplies diagnostic test kits and sanitation assays to food and feed producers, processors, grain handlers, dairies, laboratories and related manufacturers to identify pathogens, toxins, residues, allergens and other contaminants, while its Animal Safety business provides veterinary medicines, vaccines, diagnostic tools, disinfectants and genomics services, including drug-residue and toxicology testing for animals. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jan 1 | Jan 8 | NEOG | Neogen Corporation | Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential. | Closed | +38.9% |